S-Biomedic Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

S-Biomedic General Information

Description

Developer of novel therapeutics intended to establish methods to directly modulate the skin microbiome. The company's products are made by selecting beneficial bacteria that accelerate the rebalancing of a diseased microbiome and help to restore healthy skin, enabling clinicians to treat acne, eczema, rosacea, and aging.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • VIB, Suzanne Tassierstraat 1
  • 9052 Ghent
  • Belgium
+32 077
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • VIB, Suzanne Tassierstraat 1
  • 9052 Ghent
  • Belgium
+32 077

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

S-Biomedic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 15-Dec-2022 Completed Generating Revenue
9. Angel (individual) 07-Jun-2022 Completed Generating Revenue
8. Grant 31-Jan-2022 Completed Generating Revenue
7. Later Stage VC (Series A) 21-Sep-2021 Completed Generating Revenue
6. Grant 09-Oct-2019 Completed Generating Revenue
5. Grant 01-Jan-2019 Completed Generating Revenue
4. Seed Round 01-Feb-2017 Completed Generating Revenue
3. Grant Completed Startup
2. Accelerator/Incubator 01-Mar-2015 $40K $40K Completed Startup
1. Accelerator/Incubator Completed Startup
To view S-Biomedic’s complete valuation and funding history, request access »

S-Biomedic Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Ordinary 4,000 $1.77 $1.77 1x $1.77 1.79%
Preference 52,000 $1.77 $1.77 1x $1.77 23.31%
To view S-Biomedic’s complete cap table history, request access »

S-Biomedic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics intended to establish methods to directly modulate the skin microbiome. The company's pr
Drug Discovery
Ghent, Belgium
22 As of 2025

New York, NY
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

S-Biomedic Competitors (15)

One of S-Biomedic’s 15 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xalud Therapeutics Venture Capital-Backed New York, NY
MatriSys Bioscience Venture Capital-Backed San Diego, CA
PellePharm Venture Capital-Backed Palo Alto, CA
Azitra Formerly VC-backed Branford, CT
Histogen Formerly VC-backed San Ramon, CA
You’re viewing 5 of 15 competitors. Get the full list »

S-Biomedic Patents

S-Biomedic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4778510-A1 Skin care composition and uses thereof Pending 15-Jan-2025
WO-2026154084-A1 Skin care composition and uses thereof Pending 15-Jan-2025
CA-3237118-A1 Skin care composition and uses thereof Pending 12-Jan-2022
EP-4463129-A1 Skin care composition and uses thereof Pending 12-Jan-2022
US-20250295579-A1 Skin care composition and uses thereof Pending 12-Jan-2022 A61K8/99
To view S-Biomedic’s complete patent history, request access »

S-Biomedic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

S-Biomedic Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beiersdorf Venture Capital Corporate Venture Capital Minority
CG Health Ventures Venture Capital Minority
European Commission Government
European Innovation Council Accelerator/Incubator Minority
Horizon Europe Not-For-Profit Venture Capital
You’re viewing 5 of 12 investors. Get the full list »

S-Biomedic FAQs

  • When was S-Biomedic founded?

    S-Biomedic was founded in 2014.

  • Where is S-Biomedic headquartered?

    S-Biomedic is headquartered in Ghent, Belgium.

  • What is the size of S-Biomedic?

    S-Biomedic has 22 total employees.

  • What industry is S-Biomedic in?

    S-Biomedic’s primary industry is Drug Discovery.

  • Is S-Biomedic a private or public company?

    S-Biomedic is a Private company.

  • What is S-Biomedic’s current revenue?

    The current revenue for S-Biomedic is .

  • How much funding has S-Biomedic raised over time?

    S-Biomedic has raised $6.56M.

  • Who are S-Biomedic’s investors?

    Beiersdorf Venture Capital, CG Health Ventures, European Commission, European Innovation Council, and Horizon Europe are 5 of 12 investors who have invested in S-Biomedic.

  • Who are S-Biomedic’s competitors?

    Xalud Therapeutics, MatriSys Bioscience, PellePharm, Azitra, and Histogen are some of the 15 competitors of S-Biomedic.

  • When was S-Biomedic acquired?

    S-Biomedic was acquired on 15-Dec-2022.

  • Who acquired S-Biomedic?

    S-Biomedic was acquired by Beiersdorf.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process